tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ACXP Stock Latest News

Optimistic Buy Rating for Acurx Pharmaceuticals Amidst Financial Challenges and Promising Ibezapolstat Data
RatingsOptimistic Buy Rating for Acurx Pharmaceuticals Amidst Financial Challenges and Promising Ibezapolstat Data
14d ago
ACXP
Strategic Phase 3 Trials and Unique Microbiome Effects Drive Buy Rating for Acurx Pharmaceuticals
PremiumRatings
Strategic Phase 3 Trials and Unique Microbiome Effects Drive Buy Rating for Acurx Pharmaceuticals
14d ago
ACXP
Acurx Pharmaceuticals Reports 2024 Results and Advances Trials
PremiumCompany Announcements
Acurx Pharmaceuticals Reports 2024 Results and Advances Trials
14d ago
ACXP
Acurx Pharmaceuticals’ Optimistic Earnings Call Highlights Clinical Progress
PremiumCompany Announcements
Acurx Pharmaceuticals’ Optimistic Earnings Call Highlights Clinical Progress
14d ago
ACXP
Acurx price target lowered to $5 from $14 at Alliance Global Partners
PremiumThe Fly
Acurx price target lowered to $5 from $14 at Alliance Global Partners
14d ago
ACXP
Acurx reports Q4 EPS (16c) vs. (37c) last year
PremiumThe FlyAcurx reports Q4 EPS (16c) vs. (37c) last year
15d ago
ACXP
Acurx to sell 2.745M shares at 40c in registered direct offering
Premium
The Fly
Acurx to sell 2.745M shares at 40c in registered direct offering
26d ago
ACXP
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ACXP
ALLR
Acurx’s ibezapolstat shows efficacy in CDI treatment
PremiumThe Fly
Acurx’s ibezapolstat shows efficacy in CDI treatment
1M ago
ACXP
Acurx new patent granted by JPO related to DNA Polymerase IIIC Inhibitors
PremiumThe Fly
Acurx new patent granted by JPO related to DNA Polymerase IIIC Inhibitors
1M ago
ACXP
Acurx files to sell 2.61M shares of common stock for holders
PremiumThe Fly
Acurx files to sell 2.61M shares of common stock for holders
2M ago
ACXP
Acurx to sell 2.46M shares at $1.015 in registered direct offering
PremiumThe Fly
Acurx to sell 2.46M shares at $1.015 in registered direct offering
3M ago
ACXP
Acurx receives positive EMA guidance for ibezapolstat Phase 3 program
PremiumThe FlyAcurx receives positive EMA guidance for ibezapolstat Phase 3 program
3M ago
ACXP
Acurx updates Phase 3 readiness for ibezapolstat in C. difficile Infection
Premium
The Fly
Acurx updates Phase 3 readiness for ibezapolstat in C. difficile Infection
4M ago
ACXP
Acurx board approves Bitcoin as treasury reserve asset
Premium
The Fly
Acurx board approves Bitcoin as treasury reserve asset
4M ago
ACXP
Acurx supported, participated in Peggy Lillis CDI symposium
PremiumThe Fly
Acurx supported, participated in Peggy Lillis CDI symposium
4M ago
ACXP
Acurx Pharmaceuticals Reports Promising Q3 2024 Results
PremiumCompany Announcements
Acurx Pharmaceuticals Reports Promising Q3 2024 Results
5M ago
ACXP
Acurx reports Q3 EPS (17c) vs. (24c) last year
PremiumThe Fly
Acurx reports Q3 EPS (17c) vs. (24c) last year
5M ago
ACXP
Acurx’s ibezapostat shows favorable effect in Phase 2b CDI trial
PremiumThe Fly
Acurx’s ibezapostat shows favorable effect in Phase 2b CDI trial
5M ago
ACXP
Acurx’s ibezapolstat shows positive results in CDI and Anthrax
PremiumThe FlyAcurx’s ibezapolstat shows positive results in CDI and Anthrax
6M ago
ACXP
Acurx announces results of Phase 2 ibezapolstat trial in C. difficile Infection
Premium
The Fly
Acurx announces results of Phase 2 ibezapolstat trial in C. difficile Infection
6M ago
ACXP
Acurx reports Q2 EPS (26c) vs (28c) last year
Premium
The Fly
Acurx reports Q2 EPS (26c) vs (28c) last year
8M ago
ACXP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >